Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma

S. L. Gardner, J. Carreras, C. Boudreau, B. M. Camitta, R. H. Adams, Allen R Chen, S. M. Davies, J. R. Edwards, A. C. Grovas, G. A. Hale, H. M. Lazarus, M. Arora, P. J. Stiff, M. Eapen

Research output: Contribution to journalArticle

Abstract

The aim of this study was to identify risk factors associated with PFS in patients with Ewing sarcoma undergoing ASCT; 116 patients underwent ASCT in 1989-2000 and reported to the Center for International Blood and Marrow Transplant Research. Eighty patients (69%) received ASCT as first-line therapy and 36 (31%), for recurrent disease. Risk factors affecting ASCT were analyzed with use of the Cox regression method. Metastatic disease at diagnosis, recurrence prior to ASCT and performance score

Original languageEnglish (US)
Pages (from-to)867-872
Number of pages6
JournalBone Marrow Transplantation
Volume41
Issue number10
DOIs
StatePublished - May 2008

Fingerprint

Ewing's Sarcoma
Stem Cells
Therapeutics
Bone Marrow
Transplants
Recurrence
Research

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Gardner, S. L., Carreras, J., Boudreau, C., Camitta, B. M., Adams, R. H., Chen, A. R., ... Eapen, M. (2008). Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. Bone Marrow Transplantation, 41(10), 867-872. https://doi.org/10.1038/bmt.2008.2

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. / Gardner, S. L.; Carreras, J.; Boudreau, C.; Camitta, B. M.; Adams, R. H.; Chen, Allen R; Davies, S. M.; Edwards, J. R.; Grovas, A. C.; Hale, G. A.; Lazarus, H. M.; Arora, M.; Stiff, P. J.; Eapen, M.

In: Bone Marrow Transplantation, Vol. 41, No. 10, 05.2008, p. 867-872.

Research output: Contribution to journalArticle

Gardner, SL, Carreras, J, Boudreau, C, Camitta, BM, Adams, RH, Chen, AR, Davies, SM, Edwards, JR, Grovas, AC, Hale, GA, Lazarus, HM, Arora, M, Stiff, PJ & Eapen, M 2008, 'Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma', Bone Marrow Transplantation, vol. 41, no. 10, pp. 867-872. https://doi.org/10.1038/bmt.2008.2
Gardner, S. L. ; Carreras, J. ; Boudreau, C. ; Camitta, B. M. ; Adams, R. H. ; Chen, Allen R ; Davies, S. M. ; Edwards, J. R. ; Grovas, A. C. ; Hale, G. A. ; Lazarus, H. M. ; Arora, M. ; Stiff, P. J. ; Eapen, M. / Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. In: Bone Marrow Transplantation. 2008 ; Vol. 41, No. 10. pp. 867-872.
@article{92dc106137c645a787c91950b0a60ab5,
title = "Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma",
abstract = "The aim of this study was to identify risk factors associated with PFS in patients with Ewing sarcoma undergoing ASCT; 116 patients underwent ASCT in 1989-2000 and reported to the Center for International Blood and Marrow Transplant Research. Eighty patients (69{\%}) received ASCT as first-line therapy and 36 (31{\%}), for recurrent disease. Risk factors affecting ASCT were analyzed with use of the Cox regression method. Metastatic disease at diagnosis, recurrence prior to ASCT and performance score",
author = "Gardner, {S. L.} and J. Carreras and C. Boudreau and Camitta, {B. M.} and Adams, {R. H.} and Chen, {Allen R} and Davies, {S. M.} and Edwards, {J. R.} and Grovas, {A. C.} and Hale, {G. A.} and Lazarus, {H. M.} and M. Arora and Stiff, {P. J.} and M. Eapen",
year = "2008",
month = "5",
doi = "10.1038/bmt.2008.2",
language = "English (US)",
volume = "41",
pages = "867--872",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma

AU - Gardner, S. L.

AU - Carreras, J.

AU - Boudreau, C.

AU - Camitta, B. M.

AU - Adams, R. H.

AU - Chen, Allen R

AU - Davies, S. M.

AU - Edwards, J. R.

AU - Grovas, A. C.

AU - Hale, G. A.

AU - Lazarus, H. M.

AU - Arora, M.

AU - Stiff, P. J.

AU - Eapen, M.

PY - 2008/5

Y1 - 2008/5

N2 - The aim of this study was to identify risk factors associated with PFS in patients with Ewing sarcoma undergoing ASCT; 116 patients underwent ASCT in 1989-2000 and reported to the Center for International Blood and Marrow Transplant Research. Eighty patients (69%) received ASCT as first-line therapy and 36 (31%), for recurrent disease. Risk factors affecting ASCT were analyzed with use of the Cox regression method. Metastatic disease at diagnosis, recurrence prior to ASCT and performance score

AB - The aim of this study was to identify risk factors associated with PFS in patients with Ewing sarcoma undergoing ASCT; 116 patients underwent ASCT in 1989-2000 and reported to the Center for International Blood and Marrow Transplant Research. Eighty patients (69%) received ASCT as first-line therapy and 36 (31%), for recurrent disease. Risk factors affecting ASCT were analyzed with use of the Cox regression method. Metastatic disease at diagnosis, recurrence prior to ASCT and performance score

UR - http://www.scopus.com/inward/record.url?scp=44449153972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449153972&partnerID=8YFLogxK

U2 - 10.1038/bmt.2008.2

DO - 10.1038/bmt.2008.2

M3 - Article

C2 - 18246113

AN - SCOPUS:44449153972

VL - 41

SP - 867

EP - 872

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 10

ER -